Preoperative Chemoradiotherapy for Resectable Gastric Cancer.

Trevor LeongB Mark SmithersMichael MichaelKarin HaustermansRebecca WongVal GebskiRachel L O'ConnellJohn ZalcbergAlex BoussioutasMichael FindlayDavid WillisAlisha MooreWilliam K MurrayFlorian LordickChris O'CallaghanCarol SwallowGail DarlingDanielle MillerAndrew StricklandMoishe LibermanLaurent MineurR John Simesnull null

Published in: The New England journal of medicine (2024)

The addition of preoperative chemoradiotherapy to perioperative chemotherapy did not improve overall survival as compared with perioperative chemotherapy alone among patients with resectable gastric and gastroesophageal junction adenocarcinoma. (Funded by the National Health and Medical Research Council and others; TOPGEAR ClinicalTrials.gov number, NCT01924819.).

Keyphrases

locally advanced
patients undergoing
rectal cancer
squamous cell carcinoma
radiation therapy
cardiac surgery
healthcare